Key result
This review summarizes recent progress in remote monitoring technologies for cardiorespiratory activity, blood pressure, and blood glucose, including FDA-approved devices for telemedicine.
This review summarizes recent progress in remote monitoring technologies for vital signs and highlights FDA-approved devices available for telemedicine.
Remote monitoring advances may aid home cardiorespiratory and metabolic care; leaves open prospective validation for cardiovascular outcomes.
Driven by healthcare cost and home healthcare need, the development of remote monitoring technologies is poised to improve and revolutionize healthcare delivery and accessibility. This paper reviews the recent progress in the field of remote monitoring technologies that may have the potential to become the basic platforms for telemedicine. In particular, key techniques and devices for monitoring cardiorespiratory activity, blood pressure and blood glucose concentration are summarized and discussed. In addition, the US FDA approved remote vital signs monitoring devices currently available on the market are presented.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2015) reported a review. Remote monitoring technologies was evaluated. This review summarizes recent progress in remote monitoring technologies for cardiorespiratory activity, blood pressure, and blood glucose, including FDA-approved devices for telemedicine.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: